NetworkNewsBreaks

WednesdayJul 13, 2022 2:25 pm

NetworkNewsBreaks – Standard Lithium Ltd (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L) Releases Update on Key Developments

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), an innovative technology and lithium project-development company, is reporting on recent corporate and project developments. Highlights of the update include additions to SLI management, a master service agreement (“MSA”) with Telescope Innovations (“TELI”), the progress of a DFS/FEED study award and increased shareholdings by senior management. Specifically, SLI named new positions and members to its management team, including Jason Tielker as vice president of project delivery and Angus Remfry as director of project delivery. In addition, the company is reviewing Pre-FEED deliverables related to its first commercial plant with the anticipation…

Continue Reading

WednesdayJul 13, 2022 2:11 pm

NetworkNewsBreaks – Friendable Inc.’s (FDBL) 360 Offering Sees Revenue Increases, General Artist Interest to Its FeaturedX Branded Service

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced its six-month history following its acquisition of Artist Republik and FeaturedX brands/offerings. Upon these acquisitions, management has been focused on both, starting with Artist Republik, and has now just completed a phase II upgrade of FeaturedX, which the company attributes as the main contributing factor to revenue increases and ultimately surpassing the $168,000 mark from the acquisition to date. “It’s been our mission to provide a full 360 offering for all independent music artists and our team is convinced we have just that, and much more, from music distribution,…

Continue Reading

WednesdayJul 13, 2022 1:55 pm

NetworkNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) Completes Testing, Marks Milestone on Commercialization Path

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F), a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, announced that it has completed proof of concept testing designed to demonstrate the efficiencies of its 250kW 800V commercial prototype traction inverter. During the testing, the high-efficiency inverter showed reduction in switching losses of +90% compared to conventional, hard-switched inverters, which is a significant milestone for the company as it works toward commercialization. According to the announcement, a comparison of losses between soft-switching and hard-switching was calculated with Hillcrest’s system tested with 470V…

Continue Reading

TuesdayJul 12, 2022 4:45 pm

NetworkNewsBreaks – Silo Pharma Inc. (SILO) Announces Positive Results of New Study

Silo Pharma (OTCQB: SILO), a development-stage biopharmaceutical company, today announced that its novel liposomes reached a positive endpoint in animal studies showing effectiveness and reduced toxicity using a subcutaneous delivery method. “The successful results of our study show that the subcutaneous route of liposomal administration is well-suited for use in targeted drug delivery of anti-arthritic agents. We suggest that this drug delivery approach would not only enhance efficacy but also reduce systemic toxicity,” said Eric Weisblum, CEO of Silo Pharma. “In our previous work, ART-1-Cy7-liposomes injected i.v. demonstrated homing to arthritic joints and four hours was an optimal time point…

Continue Reading

TuesdayJul 12, 2022 4:38 pm

NetworkNewsBreaks – GSMI’s TA Week to Showcase Reimagined Processes to Engage, Secure Best Talent

Global Strategic Management Institute (“GSMI”), a cutting-edge conference production company focused on promoting disruptive innovation, will be hosting the upcoming Talent Acquisition (“TA”) Week in an entirely digital format between July 25-29, 2022. This July’s TA Week is set to feature three unique events in a single content-packed agenda, including the Social Recruiting Strategies Conference (“SRSC”), the Employer Branding Strategies Conference (“EBrandCon”), and the Talent Sourcing Strategies Summit (“TSSS”). An industry flagship forum catering to recruiting professionals, TA Week is designed to share comprehensive experiences to harness strategic improvements in sourcing, recruiting, and employer branding strategies and to build career-lasting…

Continue Reading

TuesdayJul 12, 2022 4:33 pm

NetworkNewsBreaks – Advisors Mortgage Group Recognized as One of New Jersey’s Best Places to Work for 10th Consecutive Year

Advisors Mortgage Group, based in Ocean Township, New Jersey, today announced recognition by NJBIZ as one of the best places to work in New Jersey. According to the announcement, this is the 10th consecutive year that the company has been awarded this accolade. NJBIZ collects the data through a survey provided by the BridgeTower Media Firm, Best Companies Group, with the details collected confidentially allowing employees to share feedback. Honorees of the 2022 NJBIZ Best Places to Work are across small (15 – 49 employees), medium (50 – 249 employees) and large (more than 250 employees) companies. “When I started…

Continue Reading

TuesdayJul 12, 2022 4:28 pm

NetworkNewsBreaks – BIT Mining Limited (NYSE: BTCM) Announces Sale of Shares to Devote Resources More Extensively to North American Market

BIT Mining (NYSE: BTCM), a leading technology-driven cryptocurrency mining company, today announced its entry into a share sale and purchase agreement with an unaffiliated third party (the “buyer”). Under the agreement, the company agreed to sell and the buyer agreed to purchase approximately 51% of the total issued share capital of Loto Interactive Limited, representing 279,673,200 shares of Loto Interactive, each at the price of HK$0.28, for the total consideration of HK$78,308,496 (the “transaction”). Upon closing of the transaction, the company’s share ownership in Loto Interactive will decrease to 8.79%. “Following our strategy to focus on developing in the U.S.,…

Continue Reading

TuesdayJul 12, 2022 4:21 pm

NetworkNewsBreaks – AmeriCann Inc. (ACAN) Achieves Record Quarterly and Monthly Revenues

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today provided financial and operational updates for its Massachusetts cannabis cultivation, product manufacturing and distribution campus. According to the announcement, the company achieved a significant increase in year-over-year quarterly revenue, reflecting growth of over 36% for the quarter ended June 2022 relative to the quarter ended June 2021, an increase of $213,902. In addition, monthly revenue for June 2022 increased 30% from June 2021. “We’re pleased with achieving record revenue for the quarter and with the strong top-line growth rate,” said AmeriCann President Tim Keogh.…

Continue Reading

TuesdayJul 12, 2022 3:24 pm

NetworkNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment

Clinilabs Drug Development Corporation, a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced commencement of enrollment in a phase 1/2a clinical trial of CYB003. Being developed by Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” CYB003 is the first novel psilocybin analog to be evaluated in phase 1/2a development for the treatment of major depressive disorder (“MDD”). “Clinilabs is honored to be working with Cybin, an innovator in the development of novel psychedelic therapeutics, to conduct its first-in-human clinical trial of CYB003,” said…

Continue Reading

TuesdayJul 12, 2022 3:08 pm

NetworkNewsBreaks – Odyssey Health Inc. (ODYY) Announces Successful Completion of Phase I Single Ascending Dosing for Intranasal Concussion Drug

Odyssey Health (OTC: ODYY), f/k/a Odyssey Group International Inc., a company focused on developing unique, life-enhancing medical products, today announced the completion of all three cohorts in its Phase I Single Ascending Dosing (“SAD”) clinical trial. According to the update, Odyssey’s trial involves administering PRV-002, the company’s novel drug to treat concussion, to healthy human subjects. Concussions represent an “unmet” medical need and affect millions worldwide, while a single concussion can significantly increase the risk of Alzheimer’s and other neuropsychiatric disorders. “After reviewing the data from Cohort III and completing the SAD analysis, I have strong confidence that PRV-002 will…

Continue Reading